Financials

  • Market Capitalization 46.69 M
  • Employee 18
  • Founded 2020
  • CEO N/A
  • Website www.tevogen.com
  • Headquarter Delaware, United States
  • FIGI BBG013395405
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.91
ratio cours/chiffre d'affaires
-67.95

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
4267
EDSA
Edesa Biotech, Inc. - Common Shares
4.80 USD+0.42%-4.19%-5.70%+104.26%46.28 M USD
4274
VERU
Veru Inc. - Common Stock
2.70 USD+0.37%-2.88%+16.38%+12.97%46.04 M USD
4276
HOWL
Werewolf Therapeutics, Inc. - Common Stock
0.97 USD+1.04%-1.02%+169.44%-25.38%47.14 M USD
4289
MGX
Metagenomi Therapeutics, Inc. - Common Stock
1.16 USD-0.85%-4.92%-2.52%-19.44%43.82 M USD

Nouvelles